RIG-I like receptors in antiviral immunity and therapeutic applications

Viruses

Volumn 3, Issue 6, 2011, Pages 906-919

  Ireton, Reneé C ^a   Gale Jr , Michael ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Inflammation; RIG I

Indexed keywords

INTERFERON; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CELL FUNCTION; CYTOKINE PRODUCTION; DENDRITE; ENTERITIS; IMMUNOSTIMULATION; IMMUNOTHERAPY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; DEAD-BOX RNA HELICASES; ENZYME ACTIVATORS; HUMANS; IMMUNITY, INNATE; VIRUS DISEASES; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUSES;

EID: 79959647082     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3060906     Document Type: Review

References (60)

1. O'Neill, L.A. Immunology. After the toll rush. Science 2004, 303, 1481-1482.
2. Saito, T.; Hirai, R.; Loo, Y.M.; Owen, D.; Johnson, C.L.; Sinha, S.C.; Akira, S.; Fujita, T.; Gale, M., Jr. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 582-587.
3. Wilkins, C.; Gale, M., Jr. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 2010, 22, 41-47.
4. Yoneyama, M.; Fujita, T. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 2010, 20, 4-22.
5. Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell 2010, 140, 805-820.
6. Barral, P.M.; Sarkar, D.; Su, Z.Z.; Barber, G.N.; DeSalle, R.; Racaniello, V.R.; Fisher, P.B. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity. Pharmacol. Ther. 2009, 124, 219-234.
7. Nakhaei, P.; Genin, P.; Civas, A.; Hiscott, J. RIG-I-like receptors: Sensing and responding to RNA virus infection. Semin. Immunol. 2009, 21, 215-222.
8. Zeng, W.; Sun, L.; Jiang, X.; Chen, X.; Hou, F.; Adhikari, A.; Xu, M.; Chen, Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141, 315-330.
9. Gack, M.U.; Shin, Y.C.; Joo, C.H.; Urano, T.; Liang, C.; Sun, L.; Takeuchi, O.; Akira, S.; Chen, Z.; Inoue, S. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446, 916-920.
10. Der, S.D.; Zhou, A.; Williams, B.R.; Silverman, R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 15623-15628.
11. Kato, H.; Takeuchi, O.; Mikamo-Satoh, E.; Hirai, R.; Kawai, T.; Matsushita, K.; Hiiragi, A.; Dermody, T.S.; Fujita, T.; Akira, S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 2008, 205, 1601-1610.
12. Loo, Y.M.; Fornek, J.; Crochet, N.; Bajwa, G.; Perwitasari, O.; Martinez-Sobrido, L.; Akira, S.; Gill, M.A.; Garcia-Sastre, A.; Katze, M.G. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 2008, 82, 335-345.
13. Hornung, V.; Ellegast, J.; Kim, S.; Brzozka, K.; Jung, A.; Kato, H.; Poeck, H.; Akira, S.; Conzelmann, K.K.; Schlee, M. et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314, 994-997.
14. Yoneyama, M.; Kikuchi, M.; Natsukawa, T.; Shinobu, N.; Imaizumi, T.; Miyagishi, M.; Taira, K.; Akira, S.; Fujita, T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5, 730-737.
15. Pichlmair, A.; Schulz, O.; Tan, C.P.; Naslund, T.I.; Liljestrom, P.; Weber, F.; Reis e Sousa, C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314, 997-1001.
16. Schmidt, A.; Schwerd, T.; Hamm, W.; Hellmuth, J.C.; Cui, S.; Wenzel, M.; Hoffmann, F.S.; Michallet, M.C.; Besch, R.; Hopfner, K.P. et al. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 12067-12072.
17. Saito, T.; Owen, D.M.; Jiang, F.; Marcotrigiano, J.; Gale, M., Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454, 523-527.
18. Uzri, D.; Gehrke, L. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J. Virol. 2009, 83, 4174-4184.
19. Hirata, Y.; Broquet, A.H.; Menchen, L.; Kagnoff, M.F. Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells. J. Immunol. 2007, 179, 5425-5432.
20. Broquet, A.H.; Hirata, Y.; McAllister, C.S.; Kagnoff, M.F. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. J. Immunol. 2011, 186, 1618-1626.
21. Chiu, Y.H.; Macmillan, J.B.; Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138, 576-591.
22. Rothenfusser, S.; Goutagny, N.; DiPerna, G.; Gong, M.; Monks, B.G.; Schoenemeyer, A.; Yamamoto, M.; Akira, S.; Fitzgerald, K.A. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 2005, 175, 5260-5268.
23. Venkataraman, T.; Valdes, M.; Elsby, R.; Kakuta, S.; Caceres, G.; Saijo, S.; Iwakura, Y.; Barber, G.N. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 2007, 178, 6444-6455.
24. Sen, G.C.; Peters, G.A. Viral stress-inducible genes. Adv. Virus Res. 2007, 70, 233-263.
25. Dong, B.; Niwa, M.; Walter, P.; Silverman, R.H. Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p. RNA 2001, 7, 361-373.
26. Malathi, K.; Dong, B.; Gale, M., Jr.; Silverman, R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448, 816-819.
27. Myong, S.; Cui, S.; Cornish, P.V.; Kirchhofer, A.; Gack, M.U.; Jung, J.U.; Hopfner, K.P.; Ha, T. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 2009, 323, 1070-1074.
28. Foy, E.; Li, K.; Sumpter, R., Jr.; Loo, Y.M.; Johnson, C.L.; Wang, C.; Fish, P.M.; Yoneyama, M.; Fujita, T. Lemon, S.M.; et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 2986-2991
29. Sumpter, R., Jr.; Loo, Y.M.; Foy, E.; Li, K.; Yoneyama, M.; Fujita, T.; Lemon, S.M.; Gale, M., Jr. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 2005, 79, 2689-2699.
30. Biron, C.A. Initial and innate responses to viral infections-Pattern setting in immunity or disease. Curr. Opin. Microbiol. 1999, 2, 374-381.
31. Bigger, C.B.; Brasky, K.M.; Lanford, R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 2001, 75, 7059-7066.
32. Chakravarthy, K.V.; Bonoiu, A.C.; Davis, W.G.; Ranjan, P.; Ding, H.; Hu, R.; Bowzard, J.B.; Bergey, E.J.; Katz, J.M.; Knight, P.R. et al. Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 10172-10177.
33. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K.J. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441, 101-105.
34. Pichlmair, A.; Schulz, O.; Tan, C.P.; Rehwinkel, J.; Kato, H.; Takeuchi, O.; Akira, S.; Way, M.; Schiavo, G.; Reis e Sousa, C. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 2009, 83, 10761-10769.
35. Cui, S.; Eisenacher, K.; Kirchhofer, A.; Brzozka, K.; Lammens, A.; Lammens, K.; Fujita, T.; Conzelmann, K.K.; Krug, A.; Hopfner, K.P. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol. Cell 2008, 29, 169-179.
36. Takahasi, K.; Kumeta, H.; Tsuduki, N.; Narita, R.; Shigemoto, T.; Hirai, R.; Yoneyama, M.; Horiuchi, M.; Ogura, K.; Fujita, T. et al. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: Identification of the RNA recognition loop in RIG-I-like receptors. J. Biol. Chem. 2009, 284, 17465-17474.
37. Eisenacher, K.; Steinberg, C.; Reindl, W.; Krug, A. The role of viral nucleic acid recognition in dendritic cells for innate and adaptive antiviral immunity. Immunobiology 2007, 212, 701-714.
38. Colonna, M.; Trinchieri, G.; Liu, Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5, 1219-1226.
39. Kato, H.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Uematsu, S.; Matsui, K.; Tsujimura, T.; Takeda, K.; Fujita, T.; Takeuchi, O.; et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23, 19-28.
40. Okano, S.; Yonemitsu, Y.; Shirabe, K.; Kakeji, Y.; Maehara, Y.; Harada, M.; Yoshikai, Y.; Inoue, M.; Hasegawa, M.; Sueishi, K. Provision of continuous maturation signaling to dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virus. J. Immunol. 2011, 186, 1828-1839.
41. Luber, C.A.; Cox, J.; Lauterbach, H.; Fancke, B.; Selbach, M.; Tschopp, J.; Akira, S.; Wiegand, M.; Hochrein, H.; O'Keeffe, M. et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 2010, 32, 279-289.
42. Johansson-Lindbom, B.; Svensson, M.; Wurbel, M.A.; Malissen, B.; Marquez, G.; Agace, W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): Requirement for GALT dendritic cells and adjuvant. J. Exp. Med. 2003, 198, 963-969.
43. Miller, C.J.; Abel, K. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV 89.6. J. Med. Primatol. 2005, 34, 271-281.
44. Hong, B.; Song, X.T.; Rollins, L.; Berry, L.; Huang, X.F.; Chen, S.Y. Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells. J. Clin. Invest. 2011, 121, 739-751.
45. Adam, C.; King, S.; Allgeier, T.; Braumuller, H.; Luking, C.; Mysliwietz, J.; Kriegeskorte, A.; Busch, D.H.; Rocken, M.; Mocikat, R. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 2005, 106, 338-344.
46. Mailliard, R.B.; Son, Y.I.; Redlinger, R.; Coates, P.T.; Giermasz, A.; Morel, P.A.; Storkus, W.J.; Kalinski, P. Dendritic cells mediate NK cell help for Th1 and CTL responses: Two-signal requirement for the induction of NK cell helper function. J. Immunol. 2003, 171, 2366-2373.
47. Martin-Fontecha, A.; Thomsen, L.L.; Brett, S.; Gerard, C.; Lipp, M.; Lanzavecchia, A.; Sallusto, F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004, 5, 1260-1265.
48. Suthar, M.S.; Ma, D.Y.; Thomas, S.; Lund, J.M.; Zhang, N.; Daffis, S.; Rudensky, A.Y.; Bevan, M.J.; Clark, E.A.; Kaja, M.K.; et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010, 6, e1000757.
49. Wang, Y.; Zhang, H.X.; Sun, Y.P.; Liu, Z.X.; Liu, X.S.; Wang, L.; Lu, S.Y.; Kong, H.; Liu, Q.L.; Li, X.H.; et al. Rig-I mice develop colitis associated with downregulation of G alpha i2. Cell Res. 2007, 17, 858-868.
50. Solis, M.; Goubau, D.; Hiscott, J. RIG-I has guts: Identification of a role for RIG-I in colitis development. Cell Res. 2007, 17, 974-975.
51. Funke, B.; Lasitschka, F.; Roth, W.; Penzel, R.; Meuer, S.; Saile, M.; Gretz, N.; Sido, B.; Schirmacher, P.; Autschbach, F. Selective downregulation of retinoic acid-inducible gene I within the intestinal epithelial compartment in crohn's disease. Inflamm. Bowel. Dis. 2011, doi:10.1002/ibd.21572.
52. Kobiyama, K.; Takeshita, F.; Ishii, K.J.; Koyama, S.; Aoshi, T.; Akira, S.; Sakaue-Sawano, A.; Miyawaki, A.; Yamanaka, Y.; Hirano, H.; et al. A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant. J. Immunol. 2009, 182, 1593-1601.
53. Wang, Y.; Cella, M.; Gilfillan, S.; Colonna, M. Cutting edge: Polyinosinic:polycytidylic acid boosts the generation of memory CD8 T cells through melanoma differentiation-associated protein 5 expressed in stromal cells. J. Immunol. 2010, 184, 2751-2755.
54. Luke, J.M.; Simon, G.G.; Soderholm, J.; Errett, J.S.; August, J.T.; Gale, M., Jr.; Hodgson, C.P.; Williams, J.A. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J. Virol. 2011, 85, 1370-1383.
55. Loo, Y.M.; Gale, M., Jr. Immune signaling by RIG-I-like receptors. Immunity 2011, 34, 680-692.
56. Horner, S.M.; Gale, M., Jr. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J. Interferon Cytokine Res. 2009, 29, 489-498.
57. Liu, H.M.; Gale, M. Hepatitis C virus evasion from RIG-I-dependent hepatic innate immunity. Gastroenterol. Res. Pract. 2010, 2010, 548390.
58. Bowie, A.G.; Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8, 911-922.
59. Ramos, H.; Gale, M. RIG-I Like Receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr. Opin. Virol. 2011. doi:10.1016/j.coviro.2011.04.004.
60. Schlee, M.; Hartmann, G. The chase for the RIG-I ligand-Recent advances. Mol. Ther. 2010, 18, 1254-1262.